Klinicheskie rekomendatsii po raku kory nadpochechnikov (Adrenokortikal’nyi rak) (Clinical Guidelines for Adrenal Cortex Cancer (Adrenocortical Cancer)), Mel’nichenko, G.A., Alekseev, B.Ya., Bel’tsevich, D.G., et al., Eds., Moscow, 2020.
Terzolo, M. and Fassnacht, M., ENDOCRINE TUMOURS: Our experience with the management of patients with non-metastatic adrenocortical carcinoma, Eur. J. Endocrinol., 2022, vol. 187, no. 3, pp. R27–R40.
Elhassan, Y.S. et al., S-GRAS score for prognostic classification of adrenocortical carcinoma: An international, multicenter ENSAT study, Eur. J. Endocrinol., 2022, vol. 186, no. 1, pp. 25–36.
Catani, M.V. et al., The “Janus face” of platelets in cancer, Int. J. Mol. Sci., 2020, vol. 21, no. 3, p. 788.
CAS PubMed PubMed Central Google Scholar
Cao, W. et al., Prognostic role of pretreatment thrombocytosis on survival in patients with cervical cancer: A systematic review and meta-analysis, World J. Surg. Oncol., 2019, vol. 17, no. 1, p. 132.
PubMed PubMed Central Google Scholar
Zhang, X. and Ran, Y., Prognostic role of elevated platelet count in patients with lung cancer: A systematic review and meta-analysis, Int. J. Clin. Exp. Med., 2015, vol. 15, no. 8 (4), pp. 5379–5387.
Gu, D. and Szallasi, A., Thrombocytosis portends adverse prognosis in colorectal cancer: A meta-analysis of 5,619 patients in 16 individual studies, Anticancer Res., 2017, vol. 37, no. 9, pp. 4717–4726.
Stone, R.L., et al., Paraneoplastic thrombocytosis in ovarian cancer, N. Engl. J. Med., 2012, vol. 366, no. 7, pp. 610–618.
CAS PubMed PubMed Central Google Scholar
Braun, A., et al., Platelet-cancer interplay: Molecular mechanisms and new therapeutic avenues, Front. On-col., 2021, vol. 11, p. 665534.
Duvernay, M.T., et al., Contributions of protease-activated receptors PAR1 and PAR4 to thrombin-induced GPIIbIIIa activation in human platelets, Mol. Pharmacol., 2017, vol. 91, no. 1, pp. 39–47.
CAS PubMed PubMed Central Google Scholar
Roşca, A.E., et al., Effects of exogenous androgens on platelet activity and their thrombogenic potential in supraphysiological administration: A literature review, J. Clin. Med., 2021, vol. 10, no. 1, p. 147.
PubMed PubMed Central Google Scholar
Khetawat, G., et al., Human megakaryocytes and platelets contain the estrogen receptor β and androgen receptor (AR): Testosterone regulates AR expression, Blood, 2000, vol. 95, no. 7, pp. 2289–2296.
Milewich, L. and Whisenant, M.G., Metabolism of androstenedione by human platelets: A source of potent androgens, J. Clin. Endocrinol. Metab., 1982, vol. 54, no. 5, pp. 969–974.
Zaslavsky, A.B., et al., Platelet-synthesized testosterone in men with prostate cancer induces androgen receptor signaling, Neoplasia, 2015, vol. 17, no. 6, pp. 490–496.
CAS PubMed PubMed Central Google Scholar
Akhvlediani, N.D., Babaev, M.U., and Solov’ev, V.V., Evolution of concepts on the role of testosterone in prostate cancer. A literature review, Androl. Genital’naya Khir., 2022, vol. 23, no. 4, pp. 26–35.
TNM Classification of Malignant Tumours, Brierley, J.D., Gospodarowicz, M.K., and Wittrkind, C., Eds., Oxford: Blackwell, 2017.
Marques, P. et al., Pre-operative serum inflammation-based scores in patients with pituitary adenomas, Pituitary, 2021, vol. 24, no. 3, pp. 334–350.
Weiss, L.M., Comparative histologic study of 43 metastasizing and nonmetastasizing adrenocortical tumors, Am. J. Surg. Pathol., 1984, vol. 8, no. 3, pp. 163–169.
Velikanova, L.I., Strel’nikova, E.G., Obedkova, E.V., et al., Generation of urinary steroid profiles in patients with adrenal incidentaloma using gas chromatography–mass spectrometry, J. Anal. Chem., 2016, vol. 71, no. 7, pp. 748–754.
Suzuki, A., Takahashi, T., Nakamura, K., Tsuyuoka, R., Okuno, Y., Enomoto, T., Fukumoto, M., and Imura, H., Thrombocytosis in patients with tumors producing colony-stimulating factor, Blood, 1992, vol. 80, no. 8, pp. 2052–2059.
Kerkhofs, T.M.A. et al., Diagnostic value of urinary steroid profiling in the evaluation of adrenal tumors, Horm. Cancer, 2015, vol. 6, no. 4, pp. 168–175.
CAS PubMed PubMed Central Google Scholar
Hong, X. et al., Systemic immune-inflammation index, based on platelet counts and neutrophil−lymphocyte ratio, is useful for predicting prognosis in small cell lung cancer, Tohoku J. Exp. Med., 2015, vol. 236, no. 4, pp. 297–304.
Hu, B. et al., Systemic immune-inflammation index predicts prognosis of patients after curative resection for hepatocellular carcinoma, Clin. Cancer Res., 2014, vol. 20, no. 23, pp. 6212–6222.
Feng, J.-F., Chen, S., and Yang, X., Systemic immune-inflammation index (SII) is a useful prognostic indicator for patients with squamous cell carcinoma of the esophagus, Medicine, 2017, vol. 96, no. 4, p. e5886.
Comments (0)